LifeClean International AB (LCLEAN) AI Stock Analysis

• Market Cap: kr41.12M
• Dividend Yield: N/A
• Average Volume (3M): 397.67K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.59
• Revenue Growth: 9.84%
• EPS Growth: 7.38%
• Country: SE
• Employees: 31
• Sector: Consumer Defensive
• Sector Strength: 66
• Industry: Household & Personal Products
• EPS (TTM): N/A
• Shares Outstanding: 274,110,400
• 10 Day Avg. Volume: 618,847
• 30 Day Avg. Volume: 397,673
• PEG Ratio: -1.40
• Price to Book (P/B): 23.52
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -16.20
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 38 Underperform
• Price Target: kr0.00 ▼(-100.00%Downside)

The overall stock score reflects significant financial weaknesses, including negative profitability and cash flow, and a bearish technical outlook. Despite top-line growth, the company's financial instability and negative valuation metrics heavily weigh down its attractiveness.

LifeClean International AB Business Overview & Revenue Model

Company Description

LifeClean International AB (LCLEAN) is a Swedish company operating in the hygiene and sanitation sector, specializing in the development and distribution of disinfectant products. The company's core offering is an advanced and patented formula designed to effectively combat a wide range of pathogens, including viruses, bacteria, and fungi. LifeClean's products are utilized across various industries, including healthcare, hospitality, and food processing, providing essential solutions for infection control and hygiene management.

How the Company Makes Money

LifeClean International AB generates revenue primarily through the sale of its disinfectant products to a diverse client base across multiple sectors. The company leverages a direct sales model as well as partnerships with distributors and agents to reach a broader market. Key revenue streams include bulk purchases by healthcare institutions, contracts with governmental agencies for sanitation purposes, and sales to the hospitality and food processing industries. Additionally, LifeClean may engage in strategic partnerships or licensing agreements to expand its market presence and enhance its product offerings. The company's earnings are significantly influenced by trends in public health and regulatory requirements for hygiene standards.

LifeClean International AB Financial Statement Overview

Summary

LifeClean International AB exhibits strong revenue growth but faces substantial challenges in profitability and financial stability. The persistent negative earnings and cash flows, coupled with a declining equity position, highlight significant risks. The company's reliance on debt financing raises concerns about long-term viability. Despite the growth in top-line revenue, the financial health of the company is precarious and requires strategic adjustments to improve profitability and reduce financial risk.

Income Statement

LifeClean International AB shows consistent revenue growth over the years, increasing from 2.3 million SEK in 2019 to 61.2 million SEK in 2024. However, the company has struggled with profitability, reflected in negative net profit margins and EBIT margins across all years. Gross profit margins have been positive, indicating some efficiency in production, but the net losses suggest high operating expenses. Overall, the income statement reflects growth potential overshadowed by persistent losses.

Balance Sheet

The balance sheet reveals a deteriorating equity position, with stockholders' equity turning negative in 2024. The debt-to-equity ratio is unfavorable due to negative equity, and the company appears heavily leveraged. The equity ratio has also been declining, indicating increasing reliance on debt financing. These factors point to significant financial risk and instability.

Cash Flow

LifeClean's cash flow shows high negative free cash flow, indicating that the company is burning cash. The operating cash flow is consistently negative, reflecting operational inefficiencies or high costs. The company's reliance on financing activities to cover cash shortfalls suggests sustainability issues in the long run.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
61.15M	52.50M	47.18M	53.36M	31.79M
	Gross Profit
26.82M	22.77M	19.52M	-30.81M	24.04M
	EBIT
-50.19M	-41.34M	-35.08M	-33.42M	-2.93M
	EBITDA
-40.87M	-32.39M	-27.79M	-26.05M	395.00K
	Net Income Common Stockholders
-53.72M	-44.24M	-36.09M	-32.75M	-3.48M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
10.57M	8.29M	11.61M	8.85M	42.45M
	Total Assets
61.80M	68.61M	76.37M	82.59M	76.47M
	Total Debt
44.90M	47.84M	32.38M	18.54M	4.45M
	Net Debt
34.33M	39.55M	20.77M	9.69M	-38.00M
	Total Liabilities
65.43M	67.29M	62.56M	32.70M	11.53M
	Stockholders Equity
-3.63M	1.31M	13.81M	49.89M	64.94M
Cash Flow		Free Cash Flow
-42.66M	-39.99M	-20.07M	-23.01M	-12.49M
	Operating Cash Flow
-40.83M	-35.46M	-16.96M	-21.79M	-5.09M
	Investing Cash Flow
-1.85M	-4.54M	-3.13M	-36.51M	-7.81M
	Financing Cash Flow
44.96M	36.67M	22.84M	24.68M	52.90M

LifeClean International AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.15
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LCLEAN, the sentiment is Negative. The current price of 0.15 is below the 20-day moving average (MA) of 0.18, below the 50-day MA of 0.23, and below the 200-day MA of 1.17, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 31.37 is Neutral, neither overbought nor oversold. The STOCH value of 14.35 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LCLEAN.

LifeClean International AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLEM	68 Neutral	kr144.01M	17.55	7.04%	―	-6.04%	-38.05%
DUNI	67 Neutral	kr4.47B	18.49	6.76%	50.79%	1.68%	-38.11%
POLYG	64 Neutral	€445.63M	28.16	-4.31%	2.29%	35.99%	95.51%
Sector *	63 Neutral	kr26.74B	12.31	189.22%	11.46%	9.05%	-18.19%
LCLEAN	38 Underperform	kr41.12M	―		―	9.84%	7.38%
QLIFE	33 Underperform	€35.21M	―		―	-63.52%	93.00%